Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

5.415 +0.085 (+1.59%)
Streaming Delayed Price Updated: 2:09 PM EDT, Jul 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 Next >
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™
From AVITA Medical
Via GlobeNewswire
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
From AVITA Medical
Via GlobeNewswire
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
See how innovation is transforming patient outcomes through real-world clinical insights and patient stories 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports First Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce First Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
Sixteen abstracts to present real-world findings and clinical innovations across AVITA Medical’s expanded portfolio, including RECELL, Cohealyx, and PermeaDerm 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Third Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
Exclusive development and distribution agreement with Regenity Biosciences provides AVITA Medical with the commercialization rights to a unique collagen-based dermal matrix following 510(k) clearance 
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Second Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Donna Shiroma retires after distinguished service as General Counsel 
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.